Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors

International Journal of Cancer

Volumn 88, Issue 2, 2000, Pages 319-322

  Tong, Dan ^a   Kucera, Elisabeth ^a   Schuster, Eva ^a   Schmutzler, Rita K ^b   Swoboda, Herwig ^a   Reinthaller, Alexander ^a   Leodolter, Sepp ^a,c   Zeillinger, Robert ^a,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d Molecular Oncology Group   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN P53;

ADULT; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; TUMOR BIOPSY;

BIOPSY; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; COMPARATIVE STUDY; DNA; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, BRCA1; GENES, P53; GENETIC MARKERS; HEAD AND NECK NEOPLASMS; HUMAN; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS;

EID: 0033818566     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001015)88:2<319::AID-IJC27>3.0.CO;2-X     Document Type: Letter

References (28)

1. BRCA1 and BRCA2 expression patterns in mitotic and meiotic cells of mice
2. Transcriptional activation by BRCA1
3. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
4. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP
5. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13
6. p53 Mutations in BRCA1-associated familial breast cancer
7. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck
8. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability
9. Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation
10. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas
11. Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients
12. Gatekeepers and caretakers
13. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma
14. Mutation and cancer: Statistical study of retinoblastoma
15. p53 Gene mutations and protein accumulation in human ovarian cancer
16. BRCA2 mutations in primary breast and ovarian cancers
17. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer
18. Transcriptional activation functions in BRCA2
19. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis
20. BRCA2 is coordinately regulated with BRCA1 during proliferation and differentiation in mammary epithelial cells
21. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers
22. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma
23. Identification of allelic losses in benign, borderline and invasive epithelial ovarian tumors and correlation with clinical outcome
24. Association of BRCA1 with Rad51 in mitotic and meiotic cells
25. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2
26. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer
27. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen
28. Allelic loss at BRCA1, BRCA2 and adjacent loci in relation to TP53 abnormality in breast cancer